Recent Updates
Recently added Catalysts
VOR Positive Sentiment Score: 65/100

Vor Bio to Participate in Upcoming Investor Conferences

Tuesday, February 21, 2023 1 min read
Key Takeaway: Vor Bio, a clinical-stage cell and genome engineering company, has announced its participation in several upcoming investor conferences. These events include the H.C. Wainwright Cell Therapy Virtual Conference, the Mizuho Oncology Therapeutics Summit, the Oppenheimer 33rd Annual Virtual Healthcare Conference, and the Barclays Global Healthcare Conference. The company's involvement in these conferences underscores its commitment to sharing advancements in developing targeted therapies for blood cancers.

Market Sentiment Analysis

POSITIVE FACTORS

  • Vor Bio is actively engaging with investors, indicating confidence in their market position.
  • Participation in multiple reputable conferences showcases the company's commitment to transparency and growth.
  • The focus on innovative cell and genome engineering technologies positions Vor Bio as a leader in blood cancer treatments.

Full Press Release Details

CAMBRIDGE, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
H.C. Wainwright Cell Therapy Virtual Conference
Fireside Chat recording available on Tuesday, February 28, 2023 at 7:00 am ET
Inaugural Mizuho Oncology Therapeutics Summit
Panel: Developing & Commercializing Cell Therapy
Date: Monday, March 13, 2023 at 8:00 am
Location: Cadillac Hotel & Beach Club, Miami, FL
Oppenheimer 33rd Annual Virtual Healthcare Conference
Presentation: Monday, March 13, 2023 at 1:20 pm ET
Barclays Global Healthcare Conference
Fireside Chat: Wednesday, March 15, 2023 at 2:05 pm ET
Location: Loews Miami Beach Hotel, Miami, FL
A live webcast and archived replay of the presentation and fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Frequently Asked Questions

What investor conferences is Vor Bio attending?

Vor Bio will participate in multiple investor conferences including H.C. Wainwright and Mizuho Oncology.

When is Vor Bio's fireside chat at H.C. Wainwright?

The fireside chat at H.C. Wainwright will be available on February 28, 2023.

Where will the Mizuho Oncology Summit take place?

The Mizuho Oncology Summit will be held at Cadillac Hotel & Beach Club in Miami.

What is Vor Bio's focus in cell therapy?

Vor Bio focuses on engineering hematopoietic stem cells for targeted therapies in blood cancers.

How can I access Vor Bio's presentations?

Live webcasts and replays of Vor Bio's presentations will be available on their investor website.

Tags: VOR Viatris Investor Conferences Healthcare investor conferences blood cancer cell therapy genome engineering
Last updated: Feb 21, 2023